ALLMedicine™ Oncology Treatment Center
Research & Reviews 343 results
https://doi.org/10.1176/appi.ps.201900480
Psychiatric Services (Washington, D.C.); Rashid A, Rickman K et. al.
Jan 20th, 2021 - Mental health stability among patients with cancer improves adherence to oncology treatment, contributing to better outcomes. In a comprehensive cancer center, the no-show rate for the psychiatric oncology clinic was higher than that of any other ...
https://doi.org/10.1007/s00432-020-03506-1 10.1093/jnci/85.5.365 10.1200/JCO.2003.09.011 10.1016/j.socscimed.2008.10.004 10.1016/j.pec.2012.02.011 10.1007/s00520-013-2016-z 10.1016/j.jpainsymman.2014.09.014 10.1634/theoncologist.2017-0490 10.1007/s00520-018-4271-5 10.1007/s00432-018-2700-y 10.1177/082585979100700202 10.1016/j.jpainsymman.2020.10.009 10.1200/JCO.2009.23.4708 10.1016/j.ctcp.2018.12.014 10.1188/10.ONF.E7-E15 10.1177/1534735418823266 10.1001/jamaoncol.2016.0685 10.1001/jamaoncol.2019.5233 10.1136/bmjspcare-2017-001351 10.1016/j.pain.2009.01.017 10.1007/s00520-017-3784-7 10.1016/j.spinee.2015.04.049 10.1016/j.jpain.2015.07.013 10.1016/j.jpainsymman.2012.06.007 10.1188/16.ONF.725-732 10.1002/pon.5039 10.1007/s00432-017-2368-8 10.1007/s00520-017-3726-4 10.1007/s00432-017-2509-0 10.1007/s00520-019-04959-y 10.1200/JCO.2013.54.4825 10.1093/jncimonographs/lgx012 10.1111/head.13148
Journal of Cancer Research and Clinical Oncology; Ben-Arye E, Elly D et. al.
Jan 12th, 2021 - The present study examined the impact of an integrative oncology treatment program in the relief of pain in patients undergoing chemotherapy and/or palliative care. In this pragmatic prospective controlled study, patients undergoing chemotherapy a...
https://doi.org/10.1016/j.crad.2020.10.018
Clinical Radiology; Veerasuri S, Little D et. al.
Jan 11th, 2021 - The last decade has seen a paradigm shift in medical oncology treatment with the rise of novel systemic agents, principally molecular targeted therapy and immunotherapy. These new groups of anti-cancer treatment have revolutionised the prognostic ...
https://doi.org/10.1007/s00520-020-05961-5 10.7314/apjcp.2015.16.17.7847 10.1097/IGC.0000000000000549 10.1001/jamaoncol.2019.0349 10.1007/s00520-016-3093-6 10.1007/s12032-017-0910-9 10.3322/caac.21397 10.1016/j.hoc.2018.01.009 10.1007/s00432-013-1464-7 10.1378/chest.07-1389 10.1016/j.ygyno.2014.10.025 10.1007/s00520-019-04682-8 10.1089/acm.2008.0589 10.3389/fonc.2019.00730 10.1093/annonc/mdq749 10.1016/j.ygyno.2011.07.099 10.1007/s00432-017-2368-8 10.1007/s00520-017-3726-4 10.1007/s00432-017-2509-0 10.1097/IGC.0b013e31820fa24a 10.1016/j.ctim.2016.07.005 10.1007/s10549-016-4010-x 10.1001/jamaoncol.2018.2487 10.1089/acm.2008.0262 10.1002/cncr.28579 10.1177/082585979100700202 10.1007/s00520-015-2934-z 10.1007/s00520-013-2016-z 10.1016/j.jbi.2014.07.003 10.1002/pon.3621 10.1016/j.ygyno.2019.10.007 10.1056/NEJMoa1000678 10.1055/s-0031-1296666 10.1097/MD.0000000000014536 10.1007/s00520-015-2690-0 10.1097/AOG.0000000000001867
Supportive Care in Cancer : Official Journal of the Multi... Segev Y, Lavie O et. al.
Jan 6th, 2021 - Integrative oncology (IO) is increasingly becoming part of palliative cancer care. This study examined the correlation between an IO treatment program and rates of survival among patients with advanced gynecological cancer. Patients were referred ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7786949
BMC Cancer; Joly-Tonetti N, Ondet T et. al.
Jan 6th, 2021 - Cutaneous adverse drug reactions (CADR) associated with oncology therapy involve 45-100% of patients receiving kinase inhibitors. Such adverse reactions may include skin inflammation, infection, pruritus and dryness, symptoms that can significantl...
Guidelines 31 results
https://doi.org/10.1016/j.kint.2020.06.046
Kidney International; Porta C, Bamias A et. al.
Oct 31st, 2020 - The association between kidney disease and cancer is multifaceted and complex. Persons with chronic kidney disease (CKD) have an increased incidence of cancer, and both cancer and cancer treatments can cause impaired kidney function. Renal issues ...
https://www.targetedonc.com/view/investigating-met-exon-14-mutations-in-patients-with-nsclc
May 28th, 2020 - Mark M. Awad, MD, PhD, clinical director of the Thoracic Oncology Treatment Center at Dana-Farber Cancer Institute and assistant professor of Medicine at Harvard Medical School, discusses the characterization of patients with non–small cell lung c...
https://www.practicalradonc.org/article/S1879-8500(18)30353-9/abstract
Wright,J.,et al
Jan 20th, 2019 - Standardization improves patient safety, efficiency, and accuracy in radiation oncology treatment. This consensus guidance represents an ASTRO quality initiative to provide recommendations for the standardization of normal tissue contouring perfor...
https://www.astro.org/Patient-Care-and-Research/Clinical-Practice-Statements/Contouring-Consensus-Guidance-Document
Jan 20th, 2019 - This document provides tabled recommendations for normal tissues contouring during external beam treatment planning for each anotomical site in all definitive cases and those that should be considered in specific clinical scenarios. Additionally, ...
https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2720582
Foster,J.
Jan 10th, 2019 - Comparative analysis revealed CRS/HIPEC to be safe, often safer across the spectrum of NSQIP safety metrics when compared with similar-risk oncologic procedures. Patient selection was important in achieving observed outcomes. High complication rat...
Drugs 2 results see all →
Clinicaltrials.gov 419 results
https://doi.org/10.1176/appi.ps.201900480
Psychiatric Services (Washington, D.C.); Rashid A, Rickman K et. al.
Jan 20th, 2021 - Mental health stability among patients with cancer improves adherence to oncology treatment, contributing to better outcomes. In a comprehensive cancer center, the no-show rate for the psychiatric oncology clinic was higher than that of any other ...
https://doi.org/10.1007/s00432-020-03506-1 10.1093/jnci/85.5.365 10.1200/JCO.2003.09.011 10.1016/j.socscimed.2008.10.004 10.1016/j.pec.2012.02.011 10.1007/s00520-013-2016-z 10.1016/j.jpainsymman.2014.09.014 10.1634/theoncologist.2017-0490 10.1007/s00520-018-4271-5 10.1007/s00432-018-2700-y 10.1177/082585979100700202 10.1016/j.jpainsymman.2020.10.009 10.1200/JCO.2009.23.4708 10.1016/j.ctcp.2018.12.014 10.1188/10.ONF.E7-E15 10.1177/1534735418823266 10.1001/jamaoncol.2016.0685 10.1001/jamaoncol.2019.5233 10.1136/bmjspcare-2017-001351 10.1016/j.pain.2009.01.017 10.1007/s00520-017-3784-7 10.1016/j.spinee.2015.04.049 10.1016/j.jpain.2015.07.013 10.1016/j.jpainsymman.2012.06.007 10.1188/16.ONF.725-732 10.1002/pon.5039 10.1007/s00432-017-2368-8 10.1007/s00520-017-3726-4 10.1007/s00432-017-2509-0 10.1007/s00520-019-04959-y 10.1200/JCO.2013.54.4825 10.1093/jncimonographs/lgx012 10.1111/head.13148
Journal of Cancer Research and Clinical Oncology; Ben-Arye E, Elly D et. al.
Jan 12th, 2021 - The present study examined the impact of an integrative oncology treatment program in the relief of pain in patients undergoing chemotherapy and/or palliative care. In this pragmatic prospective controlled study, patients undergoing chemotherapy a...
https://doi.org/10.1016/j.crad.2020.10.018
Clinical Radiology; Veerasuri S, Little D et. al.
Jan 11th, 2021 - The last decade has seen a paradigm shift in medical oncology treatment with the rise of novel systemic agents, principally molecular targeted therapy and immunotherapy. These new groups of anti-cancer treatment have revolutionised the prognostic ...
https://doi.org/10.1007/s00520-020-05961-5 10.7314/apjcp.2015.16.17.7847 10.1097/IGC.0000000000000549 10.1001/jamaoncol.2019.0349 10.1007/s00520-016-3093-6 10.1007/s12032-017-0910-9 10.3322/caac.21397 10.1016/j.hoc.2018.01.009 10.1007/s00432-013-1464-7 10.1378/chest.07-1389 10.1016/j.ygyno.2014.10.025 10.1007/s00520-019-04682-8 10.1089/acm.2008.0589 10.3389/fonc.2019.00730 10.1093/annonc/mdq749 10.1016/j.ygyno.2011.07.099 10.1007/s00432-017-2368-8 10.1007/s00520-017-3726-4 10.1007/s00432-017-2509-0 10.1097/IGC.0b013e31820fa24a 10.1016/j.ctim.2016.07.005 10.1007/s10549-016-4010-x 10.1001/jamaoncol.2018.2487 10.1089/acm.2008.0262 10.1002/cncr.28579 10.1177/082585979100700202 10.1007/s00520-015-2934-z 10.1007/s00520-013-2016-z 10.1016/j.jbi.2014.07.003 10.1002/pon.3621 10.1016/j.ygyno.2019.10.007 10.1056/NEJMoa1000678 10.1055/s-0031-1296666 10.1097/MD.0000000000014536 10.1007/s00520-015-2690-0 10.1097/AOG.0000000000001867
Supportive Care in Cancer : Official Journal of the Multi... Segev Y, Lavie O et. al.
Jan 6th, 2021 - Integrative oncology (IO) is increasingly becoming part of palliative cancer care. This study examined the correlation between an IO treatment program and rates of survival among patients with advanced gynecological cancer. Patients were referred ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7786949
BMC Cancer; Joly-Tonetti N, Ondet T et. al.
Jan 6th, 2021 - Cutaneous adverse drug reactions (CADR) associated with oncology therapy involve 45-100% of patients receiving kinase inhibitors. Such adverse reactions may include skin inflammation, infection, pruritus and dryness, symptoms that can significantl...
News 37 results
https://www.staging.medscape.com/viewarticle/938197
Sep 27th, 2020 - William Harwin, MD, founder and former president of Florida Cancer Specialists, a large multisite practice, has been indicted by a federal grand jury for conspiring to restrict patient choice and allocate medical and radiation oncology treatment i...
https://www.medscape.com/viewarticle/938197
Sep 27th, 2020 - William Harwin, MD, founder and former president of Florida Cancer Specialists, a large multisite practice, has been indicted by a federal grand jury for conspiring to restrict patient choice and allocate medical and radiation oncology treatment i...
https://www.targetedonc.com/view/investigating-met-exon-14-mutations-in-patients-with-nsclc
May 28th, 2020 - Mark M. Awad, MD, PhD, clinical director of the Thoracic Oncology Treatment Center at Dana-Farber Cancer Institute and assistant professor of Medicine at Harvard Medical School, discusses the characterization of patients with non–small cell lung c...
https://www.mdedge.com/fedprac/avaho/article/206866/breast-cancer/oncologists-agree-ai-treatment-decisions-about-half-time?channel=263
Will Pass
Aug 22nd, 2019 - When it comes to treatment recommendations for high-risk breast cancer, oncologists agree with a leading artificial intelligence platform about half the time, according to investigators. In the first study of its kind, involving 10 Chinese oncolog.
https://www.mdedge.com/fedprac/avaho/article/199676/practice-management/electronic-health-records-linked-lower-patient?channel=263
Caleb Rans
Apr 26th, 2019 - Higher reliance on electronic health records (EHRs) in ambulatory oncology practice was significantly associated with reduced safety actions among oncology nurses and prescribers, according to results of a statewide survey. “The purpose of this st.